Federal agencies are enforcing. States are legislating. If your AI governance isn't audit-ready, the window to prepare is closing.
The FTC launched enforcement actions against companies making deceptive AI claims. Five cases filed. Signal: the federal government is treating AI misrepresentation as a consumer protection issue.
The SEC designated AI as an examination priority for 2025-26. Investment advisors must disclose AI use in portfolio management and client interactions. Broker-dealers using AI-driven recommendations face heightened scrutiny.
The CFPB is actively investigating AI-driven lending discrimination. Adverse action notices must explain AI-based decisions in plain language. “The algorithm decided” is not a compliant explanation.
Extension of CCPA requiring disclosure of AI-driven profiling and automated decision-making. Applies to any company handling California residents' data — which is effectively everyone.
The most comprehensive state AI law to date. Requires impact assessments for “high-risk” AI systems, mandatory bias testing, consumer notification, and ongoing monitoring. Penalties for non-compliance.
Multiple states have AI bills in committee. The patchwork is growing. Companies operating across state lines face an increasingly complex compliance landscape.
Most mid-market companies have AI embedded in their operations — through vendors, SaaS tools, or internal experiments. Many don't have a complete inventory. You can't govern what you can't see.
Whether you deployed AI deliberately or inherited it through a vendor, you're responsible for its outputs. “We didn't know” is not a defense. Proactive assessment is the only mitigation.
Companies that build AI governance early don't just avoid penalties — they gain competitive advantage. Clients, partners, and investors increasingly ask about AI practices. Having answers builds trust.
SEC AI examination priority, CFPB lending discrimination enforcement, state consumer protection laws. Investment advisors, lenders, and broker-dealers face the most immediate pressure.
HIPAA implications for AI processing patient data, FDA AI/ML guidance for diagnostic tools, state health data privacy laws. AI in clinical settings faces the strictest scrutiny.
State insurance commissioner oversight of AI underwriting, Colorado AI Act specifically targets insurance decisions, NAIC model bulletin on AI governance.
OSHA implications for AI-driven safety systems, export control regulations for AI technology, product liability exposure from AI-assisted quality control.
State bar and CPA board guidance on AI use, client confidentiality obligations when using AI tools, professional liability considerations.
PCI DSS implications for AI in payment processing, bank regulatory oversight of AI-driven fraud detection, state money transmitter AI requirements.
Regulators don't ask which framework you follow. They ask for evidence that you're managing AI risk. Here's what that evidence needs to cover.
You need a complete inventory of every AI system in your operations — including the ones your vendors brought in. Plus documented policies for who approves new AI, who monitors it, and who's accountable. Enterprise clients and federal contractors are already asking for this. The regulators are next.
Impact assessments for high-risk AI decisions. Bias testing. Performance monitoring. If your AI touches lending, hiring, insurance, or clinical decisions, you need documented proof it's not discriminating. Colorado and California are already requiring this. More states are coming.
When a regulator asks “show me your AI governance,” you need more than a policy document. You need a continuous evidence trail — dashboards, logs, and reports that prove your controls are working. The difference between a fine and a clean bill of health is documentation.
Every engagement tier includes regulatory exposure assessment:
Includes a compliance gap scan against regulations relevant to your industry.
Comprehensive regulatory mapping with specific remediation steps.
Builds compliance milestones into your implementation timeline.
Ongoing regulatory monitoring and proactive compliance updates.
Book a discovery call. We'll map your current exposure and give you a clear picture of where you stand.
Book a Discovery Call